The current valuation score of Sonoma Pharmaceuticals Inc is 9.50, ranking 13 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.57, which is -83.22% below the recent high of -0.10 and -454.31% above the recent low of -3.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.